Towards Women participation in Scientific Research in Africa



Click here to Read the Publication

About empowering Women in Science in Africa.

This book is structured into two parts. The first part is a review of the GER of Male and Female cutting across Primary, Lower Secondary, Upper Secondary and Tertiary Institutions; from gender disparity to gender equality bringing about a paradigm shift in support for women in science. The second part is a strategic analysis conducted on a focus group that identifies the root cause and effects of less participation of women in scientific research which also portrays the methodology and analysis of the problem, with an overall objective of enhancing technical and professional competencies to accelerate Africa’s transition to innovation led knowledge-based economy. This overall objective is the second pillar of STISA-2024 for building a critical mass of technical and professional competencies. The analysis shows that there is need to carry out key activities that will spearhead a paradigm shift in women participation in scientific research.

Statistics from existing literatures have proven that ratios of female to male enrollments rate has recorded slight increase between 1990 – 2012; and it is generally observed that there is no gender parity considering the enrolment ratio of female to male as seen for instance in Sub-Saharan African tertiary education where the GER rose from 4% to 10% for men and from 2% to 6% for women between 1990 – 2012. It is noted, that fields such as education, health, welfare, humanities and arts are more populated with women than men the reason being that women tend to face more challenges in fields of study known to be men dominated like engineering, construction, manufacturing among others. There are ongoing initiatives and mechanisms being initiated by the African Union to support women education and participation which includes the Continental Educational Strategy for Africa (CESA 2016) that recognizes and supports women education and training in Africa among others.

The identification of the causative factors as to why women participate less in science was derived from a methodical gathering of root cause problems which were developed into an inventory hierarchically arranged to establish the cause and effect relationship on the problem tree. The problems identified were converted into solutions and as positive achievements that should be achievable on all areas that builds up the society to enable the achievement of the second pillar of STISA-2024.

The authors in this book have identified intervention mechanisms to be put in place for the enhancement of women participation in science.

It gives me great pleasure to share with you this publication that I co-wrote with Ahmed Hamdy, Mohammed Kyari, Marie Johnson, Ahmed Fahmi, Tiziano Peccia.

One Click on icon below to
Download Merck Foundation App

Join the conversation on our social media platforms below and let your voice be heard

 Merck Foundation

 Merck Foundation

 Merck Foundation


 Merck Foundation

About Merck Foundation

The Merck Foundation, established in 2017, is the philanthropic arm of Merck KGaA Germany, aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to quality & equitable healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website.  Please visit to read more. To know more, reach out to our social media: Merck Foundation; Facebook, Twitter, Instagram, YouTube and Flicker.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Almost 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma.